investigate possible sequence variations, DNA was extracted from an FFPE core biopsy of Kras +/Lox-G12D mouse lung tissue, which was confirmed to contain multiple adenomas by haematoxylin and eosin histological analysis (Suppl. Fig 5A) . A 180-bp region surrounding the recombined LoxP sequence was PCR amplified and cloned into a vector. Clones were screened by PCR, and 40 clones containing the 180-bp insert were sequenced. Sequence alignment revealed point mutations within 12 of Disease Models & Mechanisms: doi:10.1242/dmm.036863: Supplementary information Disease Models & Mechanisms • Supplementary information the 40 clones containing recombined LoxP (Suppl. Fig 5B) . These mutations clustered within and around the Sal1 restriction sites and occurred in intronic sequences (Suppl. Fig 5C) . Eleven of the 12 mutations were transitions (4 A>G; 1 G>A; 4 T>C; 2 C>T), and all mutations were confirmed by sequencing the opposite strand. To confirm that these mutations were not induced by errors from the DNA polymerase during PCR amplification of the insert sequence, the 140-bp WT region of Kras (co-amplified by the same primers) was also cloned. Forty clones were sequenced, and no mutations were identified (data not shown), thus confirming that the mutations observed following Cre-mediated recombination of LoxP sequences were induced by the recombination process.
Disease Models & Mechanisms: doi:10.1242/dmm.036863 BHQ1-labelled probes with some bases 'locked' (black circles) using locked nucleic acid (LNA) technology. LNA-1 targets LoxP/Sal1 on the antisense strand only, whereas LNA-2 targets LoxP/Sal1 on both the sense and antisense strands. 
